Vijaya Diagnostic Centre Limited will hold its 24th Annual General Meeting (AGM) on Friday, August 14, 2026, at 11.00 AM IST via video conferencing or other audio-visual means. The meeting is being conducted in compliance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India (SEBI). The company has dispatched the notice of the AGM and the annual report for the financial year 2025-26 to its members.

Shareholders have been informed that the facility of remote e-voting will be provided for the business to be transacted at the AGM. Detailed instructions regarding the e-voting process and other relevant information are included in the notice sent to the members. The company website will also host these details for shareholder reference.

The AGM notice and the Integrated Annual Report were sent electronically on July 20, 2026, to members whose email IDs are registered with the company's Registrar and Share Transfer Agent or Depository Participants. For members who have not registered their email addresses, a letter providing a web-link to access the Integrated Annual Report is being sent in accordance with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Members holding shares in physical mode who have not registered their email addresses can cast their votes remotely through the remote e-voting facility or via the e-voting system during the AGM. The company has appointed Central Depository Services (India) Limited (CDSL) to facilitate the electronic voting process. The same login credentials are required for attending the AGM through video conferencing.

Any queries regarding the AGM or the e-voting process may be directed to the Company Secretary. The results of the remote e-voting and e-voting at the AGM, along with the Scrutinizer Report, will be placed on the company's website and the CDSL website within two working days from the conclusion of the meeting.

Vijaya Diagnostic Centre has appointed Mr. Narasimha Raju K.A. as its Chief Financial Officer effective July 09, 2026, to strengthen its financial management and governance standards. The Board of Directors approved the appointment during a meeting held on July 09, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting commenced at 17:30 hrs and concluded at 17:40 hrs.

Mr. Narasimha Raju K.A. is a Chartered Accountant with over 20 years of experience in finance, accounting, corporate governance, and strategic leadership. His background includes working with S R Batliboi & Co, an affiliate of Ernst & Young, and senior leadership roles in healthcare, diagnostics, renewable energy, and real estate sectors. He previously served as the CFO of Vijaya Diagnostic Centre from March 15, 2021, to March 26, 2025, leading strategic initiatives including the company's initial public offering (IPO) during the COVID-19 pandemic.

Prior to rejoining, he served as the CFO of Yashoda Group of Hospitals. His expertise includes investor relations, mergers and acquisitions, financial reporting under Ind AS and IFRS, and regulatory compliance. The detailed disclosure regarding the appointment is provided in the table below: